Intensity Therapeutics, a U.S. company that produces drugs specifically designed to treat breast cancer, has presented the results of its latest studies that have proven 95% efficacy of the INT230-6 drug against cancer cells. As a result, the company’s stock value has risen by 2.5 times. In June 2023, Intensity…